These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9076953

  • 1. The rate of fibrinolysis is increased by free retraction of human gingival fibroblast populated fibrin lattices.
    Lorimier S, Bouthors S, Droulle C, Maquin DL, Maquart FX, Gillery P, Emonard H, Hornebeck W.
    Int J Biochem Cell Biol; 1997 Jan; 29(1):181-9. PubMed ID: 9076953
    [Abstract] [Full Text] [Related]

  • 2. Tissue origin and extracellular matrix control neutral proteinase activity in human fibroblast three-dimensional cultures.
    Lorimier S, Gillery P, Hornebeck W, Chastang F, Laurent-Maquin D, Bouthors S, Droulle C, Potron G, Maquart FX.
    J Cell Physiol; 1996 Jul; 168(1):188-98. PubMed ID: 8647915
    [Abstract] [Full Text] [Related]

  • 3. Morphometric studies of collagen and fibrin lattices contracted by human gingival fibroblasts; comparison with dermal fibroblasts.
    Lorimier S, Hornebeck W, Godeau G, Pellat B, Gillery P, Maquart FX, Laurent-Maquin D.
    J Dent Res; 1998 Sep; 77(9):1717-29. PubMed ID: 9759669
    [Abstract] [Full Text] [Related]

  • 4. Contribution of the plasmin/matrix metalloproteinase cascade to the retraction of human fibroblast populated collagen lattices.
    Berton A, Lorimier S, Emonard H, Laurent-Maquin D, Hornebeck W, Bellon G.
    Mol Cell Biol Res Commun; 2000 Mar; 3(3):173-80. PubMed ID: 10860866
    [Abstract] [Full Text] [Related]

  • 5. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots.
    Neuss S, Schneider RK, Tietze L, Knüchel R, Jahnen-Dechent W.
    Cells Tissues Organs; 2010 Mar; 191(1):36-46. PubMed ID: 19390164
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The fibrinolytic system: A new target for treatment of depression with psychedelics.
    Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S.
    Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
    [Abstract] [Full Text] [Related]

  • 10. Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitro.
    Runge MS, Bode C, Matsueda GR, Haber E.
    Biochemistry; 1988 Feb 23; 27(4):1153-7. PubMed ID: 3130094
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cultures of fibroblasts in fibrin lattices: models for the study of metabolic activities of the cells in physiological conditions.
    Gillery P, Bellon G, Coustry F, Borel JP.
    J Cell Physiol; 1989 Sep 23; 140(3):483-90. PubMed ID: 2777888
    [Abstract] [Full Text] [Related]

  • 14. Human dermal and gingival fibroblasts in a three-dimensional culture: a comparative study on matrix remodeling.
    Chaussain Miller C, Septier D, Bonnefoix M, Lecolle S, Lebreton-Decoster C, Coulomb B, Pellat B, Godeau G.
    Clin Oral Investig; 2002 Mar 23; 6(1):39-50. PubMed ID: 11996162
    [Abstract] [Full Text] [Related]

  • 15. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts.
    Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME, Laug WE.
    J Invest Dermatol; 1996 May 23; 106(5):1007-11. PubMed ID: 8618030
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.